Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View:Bullish
| Metric | BIIB | GILD |
|---|
| Close | 249.59 | 166.43 |
| Market Cap | $36.5B | $207B |
| 1M | +3.57% | +8.37% |
| P/E (TTM) | 104.9 | — |
| Forward P/E | 16.5 | 20.9 |
| P/E 5-Yr Percentile | 99 | — |
| P/S | 3.5 | 6.7 |
| P/B | 1.9 | 16.0 |
| Dividend Yield | — | 3.98% |
| Latest Quarter Revenue | $2.8B | $8.3B |
| Revenue YoY | +10.6% | +6.8% |
| Gross Margin | 73.3% | 81.1% |
| Latest Quarter EPS | -0.14 | 1.94 |
| Avg Post-Earnings Move | ±1.8% | ±3.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 2.65% |
| 90-Day Net Insider Buying | — | −$41.6M |
BIIB · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)